Keros Therapeutics, Inc. (KROS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.03
Day's range
$18.74

Keros Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 2.29 M $46.64 M   -15.70% 5.64%
VANGUARD GROUP INC 01/29/2026 1.53 M $31.06 M   -43.90% 3.75%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 1.33 M $27.17 M   415.75% 3.29%
STATE STREET CORP 02/13/2026 1.08 M $21.91 M   -17.42% 2.65%
MADISON AVENUE PARTNERS, LP 02/17/2026 823.71 K $16.77 M   -69.58% 2.03%
ORBIMED ADVISORS LLC 02/17/2026 804.21 K $16.37 M   -21.06% 1.98%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 783.92 K $15.96 M   158.61% 1.93%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 768.43 K $15.65 M   26.58% 1.89%
D. E. SHAW & CO., INC. 02/17/2026 755.47 K $15.38 M   -43.26% 1.86%
FEDERATED HERMES, INC. 02/12/2026 654.72 K $13.33 M   27.34% 1.61%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 635.21 K $12.94 M   -24.14% 1.56%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 591.69 K $12.05 M   282.47% 1.46%
GOLDMAN SACHS GROUP INC 02/10/2026 590.52 K $12.02 M   -55.45% 1.45%
CITADEL ADVISORS LLC 02/17/2026 472.52 K $9.62 M   168.26% 1.16%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 360.42 K $7.34 M   -70.77% 0.89%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 321.35 K $6.54 M   -4.12% 0.79%
TWO SIGMA INVESTMENTS, LP 02/17/2026 318.44 K $6.48 M   285.88% 0.78%
HRT FINANCIAL LP 02/12/2026 260.89 K $5.31 M   509.57% 0.64%
WEISS ASSET MANAGEMENT LP 02/17/2026 254.06 K $5.17 M   100.00% 0.63%
NORTHERN TRUST CORP 02/17/2026 250.57 K $5.10 M   -24.70% 0.62%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 250.00 K $5.09 M   0.00% 0.62%
MORGAN STANLEY 02/13/2026 230.49 K $4.69 M   -41.66% 0.57%
MILLENNIUM MANAGEMENT LLC 02/17/2026 220.21 K $4.48 M   312.79% 0.54%
CITADEL ADVISORS LLC 02/17/2026 203.40 K $4.14 M   334.62% 0.50%
DEUTSCHE BANK AG\ 02/11/2026 195.28 K $3.98 M   739.59% 0.48%
ALGERT GLOBAL LLC 02/17/2026 193.61 K $3.94 M   305.21% 0.48%
MAN GROUP PLC 02/17/2026 190.21 K $3.87 M   -1.37% 0.47%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 186.78 K $3.80 M   -36.04% 0.46%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 180.54 K $3.68 M   -11.65% 0.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 175.80 K $3.58 M   -19.17% 0.43%
TWO SIGMA ADVISERS, LP 02/17/2026 171.80 K $3.50 M   216.97% 0.42%
JANE STREET GROUP, LLC 02/12/2026 162.01 K $3.30 M   -0.27% 0.40%
JUMP FINANCIAL, LLC 02/17/2026 161.14 K $3.28 M   100.00% 0.40%
NOMURA HOLDINGS INC 02/17/2026 156.75 K $3.19 M   100.00% 0.39%
BESSEMER GROUP INC 02/05/2026 143.85 K $2.93 M   100.00% 0.35%
AMERIPRISE FINANCIAL INC 02/17/2026 122.83 K $2.50 M   1.99% 0.30%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 122.82 K $2.50 M   303.21% 0.30%
BANK OF NEW YORK MELLON CORP 02/10/2026 121.58 K $2.48 M   9.65% 0.30%
Y-INTERCEPT (HONG KONG) LTD 02/13/2026 117.36 K $2.39 M   141.76% 0.29%
PDT PARTNERS, LLC 02/17/2026 112.18 K $2.28 M   -66.29% 0.28%
BANK OF AMERICA CORP /DE/ 02/17/2026 100.11 K $2.04 M   -55.73% 0.25%
SG AMERICAS SECURITIES, LLC 01/09/2026 98.70 K $2.01 M   1,420.61% 0.24%
UBS GROUP AG 01/29/2026 97.08 K $1.98 M   -6.53% 0.24%
RANGELEY CAPITAL, LLC 02/17/2026 96.80 K $1.97 M   -62.57% 0.24%
INVESCO LTD. 02/19/2026 87.43 K $1.78 M   16.60% 0.22%
RBF CAPITAL, LLC 02/17/2026 81.72 K $1.66 M   -45.52% 0.20%
RUSSELL INVESTMENTS GROUP, LTD. 02/17/2026 80.77 K $1.64 M   -13.18% 0.20%
BARCLAYS PLC 02/13/2026 74.73 K $1.52 M   -24.60% 0.18%
NUVEEN, LLC 02/12/2026 63.10 K $1.28 M   -16.82% 0.16%
ENGINEERS GATE MANAGER LP 02/17/2026 62.37 K $1.27 M   136.52% 0.15%

Keros Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 207 institutional investors and hedge funds held shares of Keros Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 2.29 M

VANGUARD GROUP INC: 1.53 M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 1.33 M

STATE STREET CORP: 1.08 M

Madison Avenue Partners, LP: 823,707

ORBIMED ADVISORS LLC: 804,212

49.56% of Keros Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 23.46 M shares in the last 24 months. This purchase volume represents approximately $433.35 M in transactions.